Opening book details…
About this Medicine article
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors by Puzanov, I.; Lindsay, C. R.; Goff, L.; Sosman, J.; Gilbert, J.; Berlin, J.; Poondru, S.; Simantov, R.; Gedrich, R.; Stephens, A.; Chan, E.; Evans, T. R. J. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Puzanov, I.; Lindsay, C. R.; Goff, L.; Sosman, J.; Gilbert, J.; Berlin, J.; Poondru, S.; Simantov, R.; Gedrich, R.; Stephens, A.; Chan, E.; Evans, T. R. J.
- Publisher
- American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
- Published
- 2014
- Field
- Medicine (Health Sciences)